Paradeep Phosphates Limited has announced the appointment of Mr. Marco Philippus Ardeshir Wadia as Additional Director in the category of Independent Director. The decision was approved by the company's Board of Directors during their meeting held on March 18, 2026.

Appointment Details

The key details of Mr. Wadia's appointment are outlined below:

Professional Background

Mr. Marco Philippus Ardeshir Wadia brings extensive legal and corporate experience to the board. His professional credentials include:

• Date of Birth: January 30, 1956
• Educational Qualifications: Bachelor of Arts (Hons.) and Bachelor of Laws (LL.B.) from the University of Mumbai
• Professional Registration: Enrolled as an Advocate with the Bar Council of India
• Legal Practice: Commenced practice in 1986

Areas of Expertise

Mr. Wadia has developed comprehensive expertise across multiple domains of corporate law and governance:

• Corporate structuring and regulatory compliance
• Mergers and acquisitions advisory
• Joint ventures and strategic partnerships
• Commercial agreements and contract law
• Corporate governance frameworks

Professional Associations

Mr. Wadia has been associated with the reputed law firm Crawford Bayley & Co. as a Partner, where he has advised several leading Indian and multinational companies. He currently serves as Director or Independent Director on various companies across diverse sectors.

Regulatory Compliance

Paradeep Phosphates Limited confirmed compliance with regulatory requirements, stating that Mr. Marco Wadia has not been debarred from holding the office of Director by virtue of any SEBI Order or any other Authority. This confirmation aligns with SEBI Letter dated June 14, 2018 and NSE Circular No. NSE/CMU2018/24 dated June 20, 2018.

The Board meeting commenced at 4:30 P.M. (IST) and concluded at 5:30 P.M. (IST) on March 18, 2026. The appointment requires final approval from company members at the upcoming General Meeting.

Paradeep Phosphates Limited has completed the allotment of 2,01,605 equity shares to eligible employees under its Employee Stock Option Plan 2021 (ESOP-2021). The allotment was approved through a circular resolution passed by the company's Nomination and Remuneration Committee on February 27, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Share Capital Enhancement

The allotment has resulted in an increase in the company's issued, subscribed and paid-up equity share capital. Each newly allotted share carries a face value of Rs. 10. The impact on the company's share capital structure is detailed below:

ESOP Exercise Details

The 2,01,605 equity shares were allotted pursuant to the exercise of stock options under the company's ESOP-2021 scheme. The options were exercised at different price points by various employee groups, reflecting the grant terms applicable to different batches of option holders.

Exercise Price Structure

The ESOP options were exercised across four different price categories:

Regulatory Compliance

The allotment was conducted in accordance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company had obtained in-principle approval for 36,00,000 equity shares from both BSE Limited and National Stock Exchange of India Limited on June 13, 2023. The filing numbers assigned were 176099 for BSE and 35572 for NSE.

Share Characteristics

The newly allotted equity shares will rank pari-passu with the existing equity shares of the company in all respects. The shares have been issued in dematerialized form under ISIN INE088F01024, with distinctive numbers ranging from 1,03,79,68,990 to 1,03,81,70,594. No lock-in period applies to these shares, and no additional listing fees are payable for this allotment.

The company is listed on both BSE Limited (Scrip Code: 543530) and National Stock Exchange of India Limited (Symbol: PARADEEP), and has its registered office located at 5th Floor, Bayan Bhawan Pandit Jawaharlal Nehru Marg, Bhubaneswar, Odisha.